Insulin lispro-aabc
Insulin lispro-aabc is listed in the FDA National Drug Code directory with 19 NDC codes, marketed under brand names including LYUMJEV, LYUMJEV KwikPen, LYUMJEV Junior KwikPen. Available dosage form: injection, solution.
Drug Details
- Generic Name
- Insulin lispro-aabc
- Brand Names
- LYUMJEV, LYUMJEV KwikPen, LYUMJEV Junior KwikPen, LYUMJEV Tempo Pen
- Application Number
- BLA761109
- Sponsor
- Eli Lilly and Company
- NDC Codes
- 19
- Dosage Forms
- INJECTION, SOLUTION
- Routes
- INTRAVENOUS, SUBCUTANEOUS
- Active Ingredients
- INSULIN LISPRO
Indications and Usage
1 INDICATIONS AND USAGE LYUMJEV ® is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. LYUMJEV ® is a rapid-acting human insulin analog indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. ( 1 )